|
Real-time
OTC Markets
03:38:19 05/06/2026 HKT
|
5-day change | 1st Jan Change | ||
| 13.52 USD | +0.90% |
|
-4.25% | +1.73% |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| 08-06 | Japan Earnings Wrap: Kao, Astellas Pharma Rise; Taiyo Yuden Declines | MT |
| Market Cap | 4,173B 26.21B 22.71B 21.27B 19.4B 36.48B 2,500B 37.04B 250B 97.8B 1,252B 98.39B 96.26B | P/E 2027 * |
11.6x | P/E 2028 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4,184B 26.28B 22.77B 21.33B 19.46B 36.58B 2,506B 37.14B 251B 98.07B 1,255B 98.66B 96.51B | EV / Sales 2027 * |
1.83x | EV / Sales 2028 * | 1.79x |
| Free-Float |
98.88% | Yield 2027 * |
3.45% | Yield 2028 * | 3.56% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +0.90% | ||
| 1 week | -4.25% | ||
| Current month | -1.53% | ||
| 1 month | +2.04% | ||
| 3 months | -8.15% | ||
| 6 months | -15.82% | ||
| Current year | +1.73% |
| 1 week | 13.44 |  | 14.98 |
| 1 month | 13.04 | | 14.98 |
| Current year | 12.82 | | 17.35 |
| 1 year | 10.03 | | 17.35 |
| 3 years | 8.37 | | 17.35 |
| 5 years | 8.37 | | 18.18 |
| 10 years | 8.37 | | 18.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 01/06/2019 |
| Director/Board Member | 58 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.90% | -4.25% | - | - | 26.53B | |
| -0.47% | +2.45% | +84.89% | +126.99% | 1,088B | |
| +0.18% | +1.84% | +50.05% | +50.89% | 629B | |
| +0.71% | +2.74% | +24.36% | +64.54% | 440B | |
| -0.88% | -0.66% | +45.09% | +36.79% | 359B | |
| -0.37% | -1.15% | +26.89% | +36.10% | 291B | |
| +0.05% | -1.20% | +2.31% | +5.34% | 245B | |
| +0.54% | +3.38% | +44.66% | +60.38% | 225B | |
| -0.42% | +1.58% | -8.48% | -51.84% | 204B | |
| +0.87% | +4.84% | +14.19% | +71.81% | 168B | |
| Average | +0.16% | +1.27% | +31.55% | +44.56% | 405.47B | |
| Weighted average by Cap. | -0.03% | +1.93% | +46.53% | +65.39% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,288B 14.37B 12.45B 11.67B 10.64B 20B 1,371B 20.31B 137B 53.63B 686B 53.96B 52.78B | 2,101B 13.19B 11.43B 10.71B 9.77B 18.37B 1,258B 18.65B 126B 49.24B 630B 49.54B 48.46B |
| Net income | 343B 2.16B 1.87B 1.75B 1.6B 3B 206B 3.05B 20.59B 8.05B 103B 8.1B 7.92B | 324B 2.03B 1.76B 1.65B 1.51B 2.83B 194B 2.88B 19.43B 7.59B 97.17B 7.64B 7.47B |
| Net Debt | 11.12B 69.85M 60.52M 56.7M 51.72M 97.23M 6.66B 98.72M 667M 261M 3.34B 262M 257M | -418B -2.62B -2.27B -2.13B -1.94B -3.65B -250B -3.71B -25.04B -9.79B -125B -9.85B -9.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | US$14.79 | -0.67% | 105,914 |
| 11/08/26 | US$14.89 | -.--% | 92,707 |
| 10/08/26 | US$14.89 | +0.68% | 65,064 |
| 07/08/26 | US$14.79 | +3.50% | 66,267 |
| 06/08/26 | US$14.29 | +1.20% | 128,874 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
Select your edition
All financial news and data tailored to specific country editions
